1-2 of 2
Keywords: ANCA-associated vasculitis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis

Available to Purchase
Subject Area:
Topic Article Package: Diabetes , Nephrology
Vladimir Tesar, Zdenka Hruskova
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2015) 128 (3-4): 205–215.
https://doi.org/10.1159/000368569
Published Online: 19 November 2014
...Vladimir Tesar; Zdenka Hruskova Introduction of the standard immunosuppressive treatment has dramatically changed the outcome of patients with both ANCA-associated vasculitis and lupus nephritis, transforming them from incurable diseases with very high short-term mortality to chronic debilitating...
View articletitled, Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis
Open the PDF for Limitations of Standard Immunosuppressive Treatment in ANCA-Associated Vasculitis and Lupus Nephritis in another window
Journal Articles

Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis

Available to Purchase
Subject Area:
Nephrology
Ajay Dhaygude, Megan Griffith, Thomas Cairns, Adam McLean, Andrew Palmer, David Taube
Journal: Nephron Clinical Practice
Nephron Clinical Practice (2004) 97 (4): c154–c159.
https://doi.org/10.1159/000079175
Published Online: 17 November 2004
...Ajay Dhaygude; Megan Griffith; Thomas Cairns; Adam McLean; Andrew Palmer; David Taube Background: Cyclophosphamide has transformed the outcome of ANCA-associated vasculitis, but it is highly toxic. Recent studies have suggested that pulsed intravenous cyclophosphamide (pCyc) is an effective...
View articletitled, Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis
Open the PDF for Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis in another window